TrovaGene, Inc. Warrant
TROVW
TROVW was delisted on the 30th of May, 2017.
4 hedge funds and large institutions have $1.45M invested in TrovaGene, Inc. Warrant in 2014 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 2 reducing their positions, and closing their positions.
100% more funds holding
Funds holding: 2 → 4 (+2)
39% less capital invested
Capital invested by funds: $2.39M → $1.45M (-$933K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
U
UBS
Zurich,
Switzerland
|
+$1.44K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$5.01K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$304 |
TROVW Hedge Fund Activity: Q2 2014 in Review
4 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in TrovaGene, Inc. Warrant (TROVW) for Q2 2014, worth a combined $1.45M — down 39% from $2.39M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new TROVW positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 2 trimmed.
The largest buyer was UBS, opening a new position worth an estimated $1.44K. The largest seller was Millennium Management, cutting an estimated $5.01K.
- 4 institutional investors held TrovaGene, Inc. Warrant (TROVW) as of Q2 2014, up from 2 in Q1 2014.
- Funds reported $1.45M of TrovaGene, Inc. Warrant stock for Q2 2014, down 39% quarter-over-quarter.
- 2 funds opened new TrovaGene, Inc. Warrant positions in Q2 2014 and 0 closed out, a net change of +2 holders.
- The largest TrovaGene, Inc. Warrant buyer in Q2 2014 was UBS, an estimated $1.44K added.
- The largest TrovaGene, Inc. Warrant seller in Q2 2014 was Millennium Management, an estimated $5.01K sold.
Based on aggregated 13F filings for Q2 2014.